Voloridge Investment Management
INBX icon

Voloridge Investment Management’s Inhibrx INBX Stock Holding History

Voloridge Investment Management’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.62M Buy
48,765
+35,264
+261% +$3.53M 0.02% 548
2026
Q1 		$908K Buy
+13,501
New +$1M ﹤0.01% 897

Other funds holding INBX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Perceptive Advisors
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Schonfeld Strategic Advisors
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Voloridge Investment Management's INBX Position: Q2 2026 in Review

Voloridge Investment Management increased its Inhibrx (INBX) stake by 261% in Q2 2026, buying an estimated $3.53M and bringing the position to 48,765 shares worth $4.62M. The position accounts for 0.02% of the portfolio, ranked #548.

Voloridge Investment Management first reported a position in INBX in Q1 2026 and has held it in 2 quarters since. 162 funds tracked by Wall St. Rank hold INBX as of Q2 2026.

  • Voloridge Investment Management held 48,765 shares of Inhibrx worth $4.62M as of Q2 2026.
  • Voloridge Investment Management bought 35,264 Inhibrx shares in Q2 2026, an estimated $3.53M.
  • Inhibrx made up 0.02% of Voloridge Investment Management's portfolio in Q2 2026, its #548 holding.
  • Voloridge Investment Management first reported a position in Inhibrx in Q1 2026 and has held it in 2 quarters since.
  • 162 funds tracked by Wall St. Rank held Inhibrx as of Q2 2026.

Based on Voloridge Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.